PuSH - Publication Server of Helmholtz Zentrum München

53 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Flannick, J.* et al.: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci. Data 5:180002 (2018)
2.
Jiang, X.* et al.: Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat. Commun. 9:260 (2018)
3.
Ligthart, S.* et al.: Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am. J. Hum. Genet. 103, 691-706 (2018)
4.
Mahajan, A.* et al.: Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559-571 (2018)
5.
Mahajan, A.* et al.: Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505-1513 (2018)
6.
Aschard, H.* et al.: Evidence for large-scale gene-by-smoking interaction effects on pulmonary function. Int. J. Epidemiol. 46, 894-904 (2017)
7.
Flannick, J.* et al.: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls. Sci. Data 4:170179 (2017)
8.
Manning, A.* et al.: A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019-2032 (2017)
9.
Scott, R.A.* et al.: An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
10.
Wheeler, E.* et al.: Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med. 14:e1002383 (2017)
11.
Fuchsberger, C.* et al.: The genetic architecture of type 2 diabetes. Nature 536, 41-47 (2016)
12.
Putman, R.K.* et al.: Association between interstitial lung abnormalities and all-cause mortality. JAMA 315, 672-681 (2016)
13.
Scott, R.A.* et al.: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Sci. Transl. Med. 8:341ra76 (2016)
14.
Walford, G.A.* et al.: Genome-wide association study of the modified Stumvoll Insulin Sensitivity Index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes 65, 3200-3211 (2016)
15.
Gaulton, K.J.* et al.: Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415-1425 (2015)
16.
Gharib, S.A.* et al.: Integrative pathway genomics of lung function and airflow obstruction. Hum. Mol. Genet. 24, 6836-6848 (2015)
17.
Joshi, P.K.* et al.: Directional dominance on stature and cognition in diverse human populations. Nature 523, 459-462 (2015)
18.
Mahajan, A.* et al.: Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet. 11:e1004876 (2015)
19.
Zeller, T.* et al.: Molecular characterization of the NLRC4 expression in relation to interleukin-18 levels. Circ. Cardiovasc. Genet. 8, 717-726 (2015)
20.
Ellis, J.* et al.: Large multiethnic candidate gene study for C-reactive protein levels: Identification of a novel association at CD36 in African Americans. Hum. Genet. 133, 985-995 (2014)